INmune Bio, Inc. Announces Initiation of Clinical Program Targeting Soluble TNF to Determine if the Company’s TNF Inhibitor (DN-TNF) Platform May Prevent Complications of Cytokine Storm Caused by COVID-19

Stacey Gandler
Brand Nourishment

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs

Bud Bilanich
Success Coach

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Joey Cohen
Medication Adherence